Led · Equity · May 2026

eVoost builds an AI-driven platform to support the full commercialization cycle for residential real-estate, from market analysis and buyer persona definition to real-time recommendations on pricing, sales pace, competition and campaign optimization. The company says its technology is already used under commercial agreements covering more than $3.5 billion in real-estate assets. Headquartered in Abu Dhabi with operational presence in Madrid and Gijón, eVoost currently operates in Spain, Portugal, the UAE and the U.S., is opening Romania and plans further expansion into Italy, France and the U.K. CEO Cristian Pastrana stated the company will use the new capital to accelerate its product and technology development, expand internationally and grow the team. eVoost aims to scale its managed-asset volume and demonstrate systematic improvement in key metrics such as pricing, absorption and conversion. The company has stated targets to exceed €12M in revenues within the year and to maintain a pipeline above €4,000M in developments.

Led · Seed · Apr 2026

Golden Owl builds an intelligence operating system that fuses multi-source, multimodal data with AI-driven reasoning to generate actionable insights from complex and fragmented information environments. Its platform is designed to detect hidden patterns, influence networks, and early risk signals to support decision-making in sectors such as security, defense, and business strategy. The company offers products including Noctua and Strix, with an upcoming product named Otus. Golden Owl plans to expand its data ingestion across open, deep, and dark web sources and accelerate deployment across multiple sectors using its recent funding. Financially, it raised a €1.4 million Seed round in April 2026 led by First Drop, with support from ENISA, CDTI (NEOTEC grant), and business angels. The company is headquartered in Alicante, Spain.

Participated · Seed · Jan 2026

Stowlog, launched in 2023 by Estudio Cactus and headquartered in Castellón, Spain, delivers a modular SaaS platform that digitizes critical HSSE workflows such as access control, visitor and contractor management, and real-time geolocation for port logistics operations. The software is already live in more than 15 countries across four continents and is used by major operators including Maersk, APM Terminals, CMA CGM, and COSCO Shipping. Deployments span key ports like New York, Miami, Los Angeles, Lázaro Cárdenas, Gothenburg, and Onne, underscoring early global traction. Revenue figures were not disclosed, but the customer list and geographic footprint indicate meaningful commercial adoption less than two years after launch. With its fresh capital, the company plans to expand its team, enhance product capabilities, and scale into additional strategic markets, particularly across Europe and North America. Management positions Stowlog as a mission-critical solution that streamlines compliance and safety while reducing manual paperwork in a traditionally analog industry.

Led · Equity · Dec 2025

Founded in 2021 in Oviedo, Pragmatech develops iAST®, an AI-powered clinical decision-support tool that recommends the most appropriate antibiotic treatment and has secured CE marking as a medical device. The software has been clinically validated to cut prescribing errors and suggest therapies with lower resistance potential, addressing both patient outcomes and antimicrobial stewardship. Pragmatech operates on a B2B model, selling directly to hospitals and healthcare systems. With fresh capital in hand, the team plans a broad commercial rollout of iAST® while continuing to refine the algorithm to keep pace with evolving resistance patterns. Co-CEOs Javier Fernández and Pablo Valledor stress that the goal is to embed safe, effective AI into routine infectious-disease management. The company positions itself as a driver of digital transformation in microbiology and pharmacology. The recent €650k raise provides runway for sales expansion and further product development, but no revenue or user metrics have yet been disclosed.

Led · Equity · Nov 2025

Hair Up Laser designs and develops a medical device that uses photobiomodulation to curb the effects of androgenic alopecia, the most common form of hair loss in both men and women. The company positions its technology as a non-invasive alternative aimed at restoring patients’ hair and self-esteem, with particular emphasis on the emotional impact of alopecia on women. Fresh capital will finance a clinical trial at Hospital Sant Pau in Barcelona and complete regulatory work to meet European medical-device standards. The trial already has ethics-committee approval and is awaiting authorization from the Spanish Agency of Medicines and Medical Devices, with completion targeted for the first half of 2026. Upon successful trials, Hair Up Laser intends to secure CE marking and launch the device across Europe. The startup operates in a global hair-loss treatment market estimated at $10 billion annually, where 2.2 million people seek surgical or non-surgical solutions each year. The recent €880 k fundraise combines private investment and public support to advance the company toward commercialization.